2025 PACC Miami | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting | A Real-World Evidence Review of the CAPLA 1000+ Project
Overview
NA
Target Audience
Pharmacists
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Date of Release
November 23rd, 2025
-1763851572878.webp&w=3840&q=75)
-1763851492821.webp&w=3840&q=75)